Sarcoidosis is a multisystem disease of unknown etiology. The frequency of neurologic manifestations in sarcoidosis varies between 5 % to 15 % (7). Carpal tunnel syndrome (CTS) is the most frequently encountered entrapment neuropathy and occurs as a result of the compression of the median nerve as it passes through the carpal tunnel. CTS might be seen during the course of many systemic diseases, metabolic disorders, inflammatory arthrites, etc. (17). Although CTS during the course of various infiltrative diseases is well-known, its presence in sarcoidosis has been reported in only one series (13). In this study, we aimed to find out the frequency of CTS in sarcoidosis patients followed up at our department while evaluating the clinical features of subjects with CTS.
Sarcoidosis patients who had diseases like diabetes mellitus, hypothyroidism, amyloidosis, rheumatologic diseases, history of fracture of the arm, superimposed peripheral neuropathy, ulnar neuropathy and cervical radiculopathy, and those who did not give permission for electrophysiologic studies were excluded from the study. Patients included into study underwent electrodiagnostic study -whether they had symptoms of CTS or not -after giving written consent.
The NCS were performed with the same device (Nihon Kohden Neuropack 2) under standard conditions, and the results were evaluated by the same neurologist. Standard median and ulnar motor and midpalmar-to-wrist NCS were performed (16) . The median nerve motor NCS was considered abnormal when the distal latency exceeded 4.6 ms or the thenar compound muscle action potential (CMAP) amplitude was less than 4.0 mV. The median mixed palmar nerve action potential was regarded abnormal if the distal latency was greater than 2.2 ms or the median-ulnar palmar latency difference exceeded 0.4 ms, when a distance of 8 cm was used between stimulation and recording sites. The median palmar amplitude was considered reduced if it was smaller than 50 µV. The minimal criteria for diagnosis of CTS were taken as prolongation of the median palmar absolute latency and an abnormal median-ulnar latency difference of greater than 0.4 ms or a median-ulnar palmar difference exceeding 0.4 ms if the median-palmar latency was less than 2.3 ms. For the ulnar motor distal latency the upper limit of normal was 3.5 ms and for the hypothenar CMAP amplitude the lower limit was 6 mV. When a distance of 8 cm was used normal upper-palmar values were 2.2 ms and 15 µV. Hand temperature was monitored during study and kept at 31.5 °C or higher. If the hands were below this temperature, they were warmed in a hot water bath. Needle-electrode examination was performed in all cases and included, the first dorsal interosseous, abductor pollicis brevis, flexor pollicis longus, pronator teres.
The age, sex, radiologic stage, extrapulmonary involvement, usage of steroids and disease duration were compared between subjects who had and did not have CTS according to EPS. For statistical analysis, chi-square and Mann-Whitney U tests were used.
Results
Of 56 sarcoidosis patients included into the study, 45 (80.3 %) were females and 11 (19.7 %) were males. Demographic data concerning the 56 consecutive sarcoidosis patients are presented in Table I . Radiologically, one patient had stage 0, 29 patients stage I, 21 patients stage II, and 5 patients had stage III disease. Extrapulmonary involvement was present in 40 patients. These were erythema nodosum (17 cases), skin involvement (15 cases), uveitis (11 cases), liver involvement (10 cases), arthritis (5 cases), spleen involvement (4 cases), peripheral lymph node involvement (4 cases), parotid gland and kidney involvement (one case each). The involvement of skin, parotid gland, lymph nodes, kidney and liver was confirmed by biopsy.
When their symptoms were asked before the NCS, 10 (17.9 %) patients defined recurrent paresthesia of the hands, 12 (21.4 %) patients defined pain of the hands, and 8 (14.3 %) patients admitted being awakened from sleep by paresthesia or pain. Six (10.7 %) patients had all of the three symptoms. Of 56 patients whose NCS were available, 41 % (20 females, 3 males) had findings compatible with CTS. Three of 23 patients with CTS had only sensory median nerve lesion (pure sensory CTS), and 2 had pure median motor fibers lesion (motor CTS). Other patients had mixed CTS. None of the patients had pure axonal neuropathy.
When the clinical features of patients with and without CTS on NCS were compared, it was seen that patients with CTS had a higher frequency of symptoms associated with CTS and also had higher mean ages; however, these differences did not reach statistical significance (p>0.05). The presence of CTS was confirmed in 3 of the 6 patients who had all 3 symptoms of CTS. In addition, extrapulmonary involvement was more frequent in patients with CTS (p=0.04). The clinical features of sarcoidosis patients who had and did not have CTS are seen in Table 2 .
Discussion
CTS might complicate different connective tissue diseases and is the most common entrapment neuropathy (9) . Although various extrapulmonary complications of sarcoidosis have been defined, CTS has been reported in only a few cases. In this study, we aimed to detect the frequency of CTS in our sarcoidosis patients; 17.9 % had recurrent paresthesia of the hands, 21.4 % had pain of the hands, and 14.3 % of the subjects awakened from sleep by paresthesia or pain. However, NCS revealed CTS in 41 % of the patients. In a recent study, symptoms and/or signs of CTS were declared to be present in 44 % of the sarcoidosis patients (13) . Also, findings associated with CTS were detected in 16 % of the patients. However, the presence of CTS was confirmed by NCS in only a small proportion of the patients.
In one survey, the prevalence of symptoms related to CTS was said to be 14.4 % in the general population (1). The same study found a prevalence of electrophysiologically-confirmed, symptomatic CTS in about 3 % of women and 2 % of men. Another study from Italy reported a mean annual crude incidence of CTS in 329 cases per 100000 person-years (11). Although we did not include a control group in our study, the frequency of CTS was highly increased when compared to the general population.
In our study, we performed NCS to evaluate the frequency of CTS. As a result, we detected quite a high frequency of CTS in our sarcoidosis patients who were clinically asymptomatic. The most sensitive method used for the diagnosis of CTS is NCS (9) . It is said that Tinnel and Phalen signs have limited sensitivity and specificity (5, 8) . In studies comparing NCS and signs on physical examination, it was concluded that NCS were much more sensitive (12) . However, it was documented that NCS might yield false positive and negative results (3, 6) . In the study by Ferri et al. (3) which was performed in a community setting, only a little correlation between the patterns of hand symptoms and abnormal NCS was found. This study detected abnormal NCS in 60 % of the subjects who did not have any hand symptoms.
In this study, we observed that patients with CTS were nonsignificantly older than the others (Table 2) . Also, most patients with CTS were females. However, as the number of male sarcoidosis patients in our study was low; we were unable to make reliable statistical analysis. Studies about CTS conducted in the general population report that the frequency of CTS increases with age, and that the symptoms are seen in females more frequently (1).
It is hypothesized that wrist synovitis and granuloma deposition on the transverse carpal ligament -similar to the case in amyloidosis-might play a role in the development of CTS in sarcoidosis patients (13) . In one sarcoidosis patient with CTS, noncaseified granulomas were demonstrated on the flexor retinaculum (10) . Also, rarely the presence of noncaseified granulomas were shown on the nerve itself (15) . In our study, biopsy was performed in none of the cases. Wrist synovitis was a little more frequent in our patients with CTS, the difference was not significant. Niemar et al. (13) reported a decreased incidence of Tinnel sign in their patients using steroids -probably, due to suppression of the inflammation of the median nerve; however, the incidence of steroid usage was not significantly different between our patients with and without CTS.
Peripheral neuropathy is one of the main types of neurologic involvement seen during the course of sarcoidosis (7) . In one study, it was reported in 33 % of the cases (4). Peripheral neuropathy during the course of sarcoidosis is a late sign and implies a disease with a chronic course (4,7). We excluded patients with known peripheral neuropathy at the beginning of our study; and we did not diagnose sarcoidosis-related neuropathy in any of our patients. The disease duration in our patients with CTS was no different than the others. However, the frequency of extrapulmonary involvement was higher in subjects with CTS. Our results suggest that rather than disease duration, disease with extrapulmonary findings increases the risk of CTS.
The NCS findings suggest that CTS is common in sarcoidosis, and electrophysiologic examination is the method of diagnosis in the early, asymptomatic period of CTS. Further studies need to be conducted to enlight the etiopathogenesis of CTS in sarcoidosis. In addition, asymptomatic patients with positive findings on NCS need to be followed up for the development of symptomatic CTS. 
